Aminopeptidase A inhibitors

Expert Opinion on Therapeutic Patents

Volumn 11, Issue 3, 2001, Pages 431-444

  David Basei, C ^a   Fournie Zaluski M C ^a   Roques, B P ^a  

^a CNRS   (France)

Author keywords

Angiotensin; Cancer; Cholecystokinin; Hypertension; Inhibitor; Zinc metalloaminopeptidase

Indexed keywords

AMASTATIN; ANGIOTENSIN; ANGIOTENSIN III; ARPHAMENINE B; ASPARTATE THIOL; ASPARTIC ACID DERIVATIVE; BROMOMETHYLKETONE; CARBOXYLIC ACID; CHLOROMETHYL KETONE; CHOLECYSTOKININ; CHOLECYSTOKININ OCTAPEPTIDE; GLUTAMATE THIOL; GLUTAMIC ACID DERIVATIVE; GLUTAMYL AMINOPEPTIDASE; HYDROXAMIC ACID; INTERLEUKIN 7; LEUHISTIN; METALLOPROTEINASE; PEPTIDE; PEPTIDE HYDROLASE INHIBITOR; PHEBESTIN; PHOSPHATE; PHOSPHONIC ACID DERIVATIVE; PROBESTATIN; PROBESTIN; THIOL; THIOL DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASOCONSTRICTOR AGENT; VASOPRESSIN; ZINC;

BLOOD PRESSURE; BRAIN TISSUE; CANCER CHEMOTHERAPY; CELL PROLIFERATION; DRUG DESIGN; DRUG METABOLISM; DRUG POTENCY; DRUG STRUCTURE; ESSENTIAL HYPERTENSION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; PATENT; PERIPHERAL VASCULAR SYSTEM; PHYSIOLOGY; REVIEW; VASOCONSTRICTION; VASOPRESSIN RELEASE;

EID: 0035117613     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.11.3.431     Document Type: Review

References (52)

1. Glutamyl aminopeptidase (aminopeptidase A), the BP-1/6C3 antigen
2. Histidine residue in the zinc binding motif of aminopeptidase A is critical for enzymatic activity
3. Evolutionary families of metallopeptidases
4. Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: Predominant role of angiotensin III in the control of vasopressin release
5. Characterization of angiotenin IV degrading enzymes and receptors on rat mesangial cells
6. Inhibition of zinc peptidases that hydrolyse neuropeptides
7. Aminopeptidase A inhibitors as potential central antihypertensive agents
8. 8) is essentially ensured by aminopeptidase A
9. CCK-B receptor: Chemistry, molecular biology biochemistry and pharmacology
10. Neutral endopeptidase 24.11: Structure, inhibition and experimental and clinical pharmacology
11. Novel approaches to targeting neuropeptide systems
12. Study on aminopeptidase A
13. Aminopeptidase A: Distribution in rat brain nuclei and increased activity in spontaneously hypertensive rat
14. Lateralization of aminopeptidase A activity in substantia nigra, striatum and frontal cortex of rats
15. Aminopeptidase A activity in the murine B-lymphocytes differentiation antigen BP-1/6C3
16. cDNA cloning and expression of human glutamyl aminopeptidase (aminopeptidase A)
17. Molecular cloning of the human kidney differentiation antigen gp160: Human aminopeptidase A
18. The mouse BP-1 gene: Structure, chromosomal localization and regulation of expression by Type I interferons and interleukin-7
19. Production and properties of a recombinant soluble form of aminopeptidase A
20. A soluble aspartate aminopeptidase from dog kidney
21. An aminopeptidase from mouse brain cytosol that cleaves N-terminal amino acid residues
22. Purification, characterization and cloning of a cytosolic aspartyl aminopeptidase
23. Identification of glutamate residues essential for catalytic activity and zinc coordination in aminopeptidase A
24. A tyrosine residue essential for catalytic activity in aminopeptidase A
25. 350 as a critical residue involved in the N-terminal amine binding site of aminopeptidase N (E.C.3.4.11.2): Insights into its mechanism of action
26. A glutamate residue contributes to the exopeptidase specificity in aminopeptidase A
27. Structural basis of the action of thermolysin and related zinc peptidases
28. Differences in transition state stabilization between thermolysin (EC 3.4.24.27) and neprilysin (EC3.4.24.11)
29. Proteins of the kidney microvillar membrane. Aspartate aminopeptidase: Purification by immunoabsorbent chromatography and properties of the detergent- and proteinase-solubilized forms
30. 2+, contributes to the substrate specificity of aminopeptidase A
31. Structure and chemical synthesis of amastatin
32. Synthesis and structure-activity relationships of amastatin analogues, inhibitors of aminopeptidase A
33. Inhibition of aminopeptidases N, A and W. A re-evaluation of the actions of bestatin and inhibitors of angiotensin converting enzyme
34. Probestin, a new inhibitor of aminopeptidase M, produced by Streptomyces azureus MH663-2F6. II. Structure determination of probestin
35. Phebestin, a new inhibitor of aminopeptidase N, produced by Streptomyces sp. MJ716-m3
36. Leuhistin, a new inhibitor of aminopeptidase M, produced by Bacillus laterosporus BM1156-14F1. I. Taxonomy, production, isolation, physico-chemical properties and biological activities
37. Arphamenine A and B, new inhibitors of aminopeptidase B, produced by bacteria
38. Inhibition of the formation of angiotensin III
39. Inhibition of angiotensin III formation by thiol derivatives of acidic amino acids
40. Investigation of the active-site of aminopeptidase A using a series of new thiol-containing inhibitors
41. Differential inhibition of aminopeptidase A and aminopeptidase N by new β-amino thiols
42. 8: A microdialysis study
43. Inhibition of vasopressinergic neurons by central injection of a specific aminopeptidase A inhibitor
44. Inhibition of aminopeptidases by phosphonic acid analogues of aspartic and glutamic acids
45. Investigation of susbsite preferences in aminopeptidase A (EC 3.4.11.7) led to the design of the first highly potent and selective inhibitors of this enzyme
46. 125I]-iodotyrosine-1-aspartic acid: A radiolabelled inhibitor of aminopeptidase A
47. Phosphinic derivatives as new dual enkephalin degrading enzyme inhibitors: Synthesis, biological properties and antinociceptive activities
48. 1 position
49. T and B cell development in BP-1/6C3/Aminopeptidase A-deficient mice
50. Reduction of plasma glutamyl aminopeptidase activity in sporadic Alzheimer's disease
51. Specificity analysis of mouse monoclonal antibodies defining cell surface antigens of human renal cancer
52. Expression and localization of aminopeptidase A, aminopeptidase N and dipeptidyl peptidase IV in benign and malignant human prostate tissue